医学
阿司匹林
血运重建
经皮冠状动脉介入治疗
P2Y12
急性冠脉综合征
心脏病学
内科学
传统PCI
氯吡格雷
外科
心肌梗塞
作者
Khawaja Hassan Akhtar,Usman Baber
标识
DOI:10.1016/j.mcna.2023.12.003
摘要
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is recommended for at least 6 and 12 months following percutaneous coronary intervention with drug-eluting stents among patients with stable ischemic heart disease and acute coronary syndrome, respectively. Additional exposure to antiplatelet therapy reduces ischemic events but also increases bleeding risk. Conversely, shorter durations of DAPT are preferred among those at high bleeding risk. Hence, decisions surrounding duration of DAPT after revascularization should include clinical judgment, assessment of the risk of bleeding and ischemic events, and time after revascularization.
科研通智能强力驱动
Strongly Powered by AbleSci AI